WO2018127907A1 - Fil chirurgical pour chirurgie plastique - Google Patents

Fil chirurgical pour chirurgie plastique Download PDF

Info

Publication number
WO2018127907A1
WO2018127907A1 PCT/IL2018/050002 IL2018050002W WO2018127907A1 WO 2018127907 A1 WO2018127907 A1 WO 2018127907A1 IL 2018050002 W IL2018050002 W IL 2018050002W WO 2018127907 A1 WO2018127907 A1 WO 2018127907A1
Authority
WO
WIPO (PCT)
Prior art keywords
tissue
sleeve
thread
tissue ingrowth
proximal end
Prior art date
Application number
PCT/IL2018/050002
Other languages
English (en)
Inventor
Ran TALISMAN
Original Assignee
Talisman Ran
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Talisman Ran filed Critical Talisman Ran
Publication of WO2018127907A1 publication Critical patent/WO2018127907A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06066—Needles, e.g. needle tip configurations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00792—Plastic surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0427—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0446—Means for attaching and blocking the suture in the suture anchor
    • A61B2017/0461—Means for attaching and blocking the suture in the suture anchor with features cooperating with special features on the suture, e.g. protrusions on the suture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0464—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors for soft tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06066—Needles, e.g. needle tip configurations
    • A61B2017/061—Needles, e.g. needle tip configurations hollow or tubular

Definitions

  • This invention relates to surgical devices for pulling a soft tissue. More particularly, to thread based devices for lifting and or lagging tissue, for example, facial tissue, during plastic surgery.
  • Surgical threads used in the procedural aesthetic field are well known.
  • the threads all have the following characteristics: minimal skin cut for insertion (usually a needle prick), durability (as much as the material and the diameter allows), the actual threads are usually in one direction but can be multi-directional and have variable lengths.
  • the logic behind using a thread varies and depends on the nature of the threads.
  • Single straight threads, with or without inherent spring effect, such as cogs, are based on the rationale that insertion of a thread into the sub-cutis causes collagen to form around and tighten the tissue, which improves its appearance.
  • Double armed needle threads e.g.
  • SilouhtteTM with or without spring effect, generally rely on a tissue pulling effect, which are based on the rationale that insertion of a thread into the sub- cutis plane from the relatively non-mobile tissue into mobile tissue will bring about immediate pulling of the mobile tissue and fixation after the move using the threads as anchoring aids.
  • collagen is built up around the thread/tissue which tightens it to enhance the effect.
  • a thread that was developed in Russia has been widely used internationally, but it has not yet been cleared by the FDA. It is a bidirectional, free-floating thread that is placed through a hollow needle. After the needle is placed, the tissues are compressed over the needle, which is then withdrawn, causing the cogs to engage the tissues and support them. Theoretically this enables rapid placement of the threads.
  • the disadvantages, which are related to the thread's free-floating nature include more frequent migration with exposure, reduced duration of the effect, and sometimes inappropriate bunching of the tissues being lifted.
  • Another thread developed by Woffles Wu, MD, in Singapore is a long bidirectional suture, with cogs converging toward a central 8-cm non-barbed section.
  • the main drawback of the currently known threads is the "Swiss cheese” effect.
  • the threads cut through the tissue instead of pulling/lifting it.
  • the lifting effect in currently used threads is typically only due to secondary collagen formation.
  • a device and method for pulling a moveable soft tissue towards a solid soft tissue for example, for lifting of the soft tissue.
  • the device disclosed herein which may also be referred to as TSALTTM according to some embodiments, is designed to create an optimal, optionally plastic no n- surgical thread configured to provide maximal lagging between stable and moveable soft tissue in the face, body and extremities by allowing tissue ingrowth around and into the suture, for example by using the herein disclosed tissue compatibility and locking mechanism.
  • the TSALTTM provides maximum tissue bonding between the thread and the moving tissue. Furthermore, due to the lagging, maximal compression or pulling between stable tissue and moving tissue is achieved.
  • a medical device for plastic surgery includes a thread and a tissue ingrowth element located at or associated with a distal section of the thread.
  • the tissue ingrowth element such as a biocompatible net or mesh, is configured to allow soft tissue growth therein.
  • the device optionally further includes a pulling element (such as, but not limited to, a ring) at or associated with a proximal section of the thread.
  • the pulling element is configured to allow efficient pulling of the thread, thus allowing pulling/lifting of soft tissue associated with the tissue ingrowth element, towards a stable tissue.
  • a tissue lagging device for plastic surgery, the device comprising a biocompatible and bio -absorbable hollow sleeve forming an open-ended lumen, the lumen having a proximal end and a distal end; wherein the sleeve is configured for implantation into the tissue between an entrance and an exit point of the tissue; a biocompatible and bio-absorbable thread slidingly extending along a length of the lumen; wherein a proximal end of the thread extends out of the sleeve's proximal end; a tissue ingrowth member attached to a distal end of the thread, the tissue ingrowth member configured for tissue ingrowth; and a locking mechanism configured to lock the thread within the sleeve, such that when the thread is pulled and tissue associated with the tissue ingrowth member is lifted, distal movement of the tissue ingrowth member is prevented.
  • the device further comprises a tissue piercing member having a sharp distal end, said tissue piercing member being detachably connected to said sleeve's distal end and configured to penetrate the tissue at the entrance point and to allow passage of the device until exiting the exit point.
  • the tissue piercing member is a trocar having a shape of a smooth cone.
  • the locking mechanism comprises an anchoring element positioned on a part of the thread positioned within the hollow sleeve, proximally to the tissue ingrowth member, and an anchoring site formed in an inner wall of the sleeve's proximal end, the anchoring site configured to secure the anchoring element, thereby preventing distal movement of the thread and the tissue ingrowth member.
  • the anchoring element comprises one or more unidirectional absorbable cones and the anchoring site comprises one or more rails/shelves configured to secure the cones therein.
  • the sleeve comprises a stopper attached to the sleeve's proximal end, the stopper configured to abut the entrance point, thereby preventing the sleeve from moving distally, toward/through the exit point.
  • the stopper is detachable from the sleeve.
  • the device further comprises a pulling member attached to the thread's proximal end, wherein the pulling member is configured to allow a user to pull the thread proximally, thereby causing a lifting of tissue and/or lagging associated with the tissue ingrowth member.
  • the device further comprises one or more wings, wherein the one or more wings are configured to anchor the sleeve to surrounding tissue. According to some embodiments, the one or more wings are positioned on an outer surface of the sleeve's proximal end.
  • the tissue ingrowth member is a net.
  • a method for lagging tissue in a plastic surgery of a subject comprising: inserting a tissue lagging device into a target tissue, wherein the tissue lagging device comprises: a biocompatible and bio -absorbable hollow sleeve forming an open-ended lumen, the lumen having a proximal end and a distal end; a biocompatible and bio-absorbable thread slidingly extending along a length of the lumen; wherein a proximal end of the thread extends out of the sleeve's proximal end; a tissue ingrowth member attached to a distal end of the thread, the tissue ingrowth member configured for tissue ingrowth; and a locking mechanism positioned on a part of the thread positioned within the hollow sleeve, proximally to the tissue ingrowth member, and wherein the inserting comprises penetrating the subject's skin at an entrance point, passing the device through the tissue until an exit point in the subject
  • the inserting further comprises passing the device through the tissue until a stopper abuts the entrance point, thereby positioning the sleeve within the tissue, between the entrance and exit points.
  • the penetrating of the subject's skin at the entrance and exit points is performed using a tissue piercing element attached to a distal end of the hollow sleeve.
  • the method further comprises detaching the tissue piercing element from the sleeve following the penetration of the exit point.
  • the pulling is performed using a pulling member attached to the thread's proximal end.
  • the locking comprises anchoring an anchoring element, positioned on a part of the thread located within the hollow sleeve, proximally to the tissue ingrowth member, to an anchoring site formed in an inner wall of the sleeve's proximal end.
  • the anchoring element comprises one or more unidirectional absorbable cones, and wherein the anchoring site comprises one or more stopper shelves configured to secure the one or more cones therein.
  • the method further comprises further comprising detaching the stopper and/or the pull member from the sleeve.
  • Figure 1 schematically depicts a surgical device, according to an exemplary embodiment of the current invention
  • Figure 2 schematically depicts the surgical device of Figure 1 in a first operation position, according to an exemplary embodiment of the current invention
  • Figure 3 schematically depicts a surgical device of Figure 1 in a second operation position, according to an exemplary embodiment of the current invention.
  • Figure 4 schematically depicts a surgical device of Figure 1 in a third operation position, according to an exemplary embodiment of the current invention.
  • a tissue lifting and/or tissue lagging device including a biocompatible and bio-absorbable hollow sleeve forming an open-ended lumen, the lumen having a proximal end and a distal end; a bioimplantable thread slidingly extending along a length of the lumen; and a tissue ingrowth member attached to a distal end of the thread, the tissue ingrowth member configured to promote tissue ingrowth.
  • the sleeve is configured for implantation into the tissue between an entrance and an exit point of a subject's skin.
  • the sleeve may be made of any flexible, biocompatible and bio- absorbable material, such as, but not limited to, purified collagen (e.g. bovine collagen), polyglycolic acid (optionally coated with N-laurin and L-lysine), polyester, poly (p- dioxanone), glycolide, 1-lactide, p-dioxanone, trimethylene carbonate and ⁇ - caprolactone or any combination thereof.
  • purified collagen e.g. bovine collagen
  • polyglycolic acid optionally coated with N-laurin and L-lysine
  • polyester poly (p- dioxanone), glycolide, 1-lactide, p-dioxanone, trimethylene carbonate and ⁇ - caprolactone or any combination thereof.
  • the sleeve lumen may have a diameter in the range of 0.5 mm-5mm, lmm-4.5mm, 1.5mm-4.5mm, 1.5mm-3.5 mm or any other suitable diameter range within the range of 0.5mm-5mm. Each possibility is a separate embodiment.
  • the sleeve is configured for implantation and remains embedded in the tissue until absorbed.
  • a thread (also referred to as a suture) may be made of any flexible, biocompatible and bio-absorbable material capable of withstanding a persistent pull force, such as, but not limited to, purified collagen (e.g. bovine collagen), polyglycolic acid (optionally coated with N-laurin and L-lysine), polyester, poly (p-dioxanone), glycolide, 1-lactide, p-dioxanone, trimethylene carbonate and ⁇ -caprolactone or any combination thereof.
  • the thread may have tensile retention for at least 5 days, at least 7 days, at least 10 days or at least 14 days. Each possibility is a separate embodiment.
  • the proximal end of the thread extends out of the sleeve's proximal end.
  • the thread may be a multifilament thread.
  • the thread may be braided. Additionally or alternatively, the distal end of the thread extends out of the sleeve's distal end.
  • the term "absorbable”, with referral for example to the thread and/or the sleeve, refers to the ability of the thread/sleeve to be degraded/disintegrated naturally by the body, without leaving foreign material requiring further procedure.
  • the thread/sleeve may be absorbed by any of a various of processes including hydrolysis (polyglycolic acid), and proteolytic enzymatic degradation.
  • the thread and/or the sleeve may be absorbed within ten days to eight weeks, thus allowing healing of the tissue prior to being absorbed.
  • biocompatible refers to the capability of the thread/sleeve to exist in harmony with tissue without causing deleterious changes.
  • tissue ingrowth member may refer to any suitable, biocompatible and bio -absorbable material configured to promote tissue growth therein, such as, but not limited to, purified collagen (e.g. bovine collagen), polyglycolic acid (optionally coated with N-laurin and L-lysine), polyester, poly (p- dioxanone), glycolide, 1-lactide, p-dioxanone, trimethylene carbonate and ⁇ - caprolactone or any combination thereof.
  • tissue ingrowth members include tissue growth promoting meshes and/or nets. According to some embodiments, the tissue ingrowth member is attached to a distal end of the thread.
  • pulling of the thread causes backward movement of the tissue ingrowth member towards the sleeves proximal end.
  • the pulling member may be any member, having any suitable shape, allowing convenient grasping and pulling of the thread.
  • a non-limiting example of a suitable pulling member includes a ring attached to the thread's proximal end.
  • the device further includes a locking mechanism configured to lock and/or immobilize the thread within the sleeve lumen, thereby preventing distal movement thereof. Without being bound by any theory, this may ensure that the tissue associated with the tissue ingrowth member will be lagged to the tissue, towards which it is pulled.
  • the locking mechanism may include an anchoring element and an anchoring site.
  • the anchoring element may be positioned on the part of the thread positioned within the hollow sleeve, proximally to the tissue ingrowth member.
  • the anchoring site may be formed in an inner wall of the sleeve's proximal end.
  • the anchoring site is configured to secure/fasten/lock the anchoring element, thereby preventing distal movement of the thread and thus of the tissue ingrowth member.
  • the anchoring element may include one or more unidirectional absorbable cones, and the anchoring site may include one or more rails/shelves configured to secure/lock/engage therein the cones.
  • the term “lagging” refers to compression of one tissue to another tissue, specifically, to pulling and securing moveable soft tissue associated with the tissue ingrowth member of the device to the stable tissue.
  • the device includes a tissue piercing member having a sharp distal end.
  • the tissue piercing element may be a trocar.
  • the trocar may be shaped as a smooth cone, optionally made of metal.
  • the tissue piercing member may be detachably connected to the sleeve's and/or thread's distal end.
  • the tissue piercing member may be configured to penetrate the subject's skin at the entrance point (e.g. beneath the subject's cheek bone) and to allow passage of the device until exiting the skin at an exit point (e.g. in the area of the lower check).
  • the sleeve includes a stopper at its proximal end, the stopper being configured to prevent the sleeve from moving distally, toward the exit point, when the stopper abuts the entrance point.
  • the stopper may have any number of configurations, capable of enlarging the sleeve' s outer circumference or otherwise preventing the sleeve from sliding distally beyond the entrance point.
  • the stopper may be ring-shaped so as to circumferentially engage an outer surface of the sleeve's proximal end.
  • the stopper may include a plurality of elements circumferentially spaced apart around the outer surface of the sleeve's proximal end. According to some embodiments, the stopper is detachable from the sleeve. This advantageously allows removing the stopper at the end of the procedure, as further described herein.
  • the device includes a pulling member attached to the thread's proximal end.
  • the pulling member is configured to allow a user to pull the thread proximally (i.e. in direction of the entrance point), thereby causing a lifting/lagging of the tissue associated with the tissue ingrowth member.
  • the pulling member may be a pulling ring, however other configurations allowing physicians (or other users) to efficiently grasp and pull the thread are also applicable and within the scope of this disclosure.
  • the device includes further one or more wings, hooks, prongs or other suitable element configured to anchor the sleeve to surrounding tissue.
  • the wings, hooks, prongs or other suitable element are positioned on an outer surface of the sleeve's proximal end.
  • a method for tissue lagging for plastic surgery comprising: inserting a tissue lagging device into a target tissue, wherein the device includes a biocompatible and bio-absorbable hollow sleeve forming an open-ended lumen, the lumen having a proximal end and a distal end; a biocompatible thread slidingly extending along a length of the lumen; wherein a proximal end of the thread extends out of the sleeve's proximal end; a tissue ingrowth member attached to a distal end of the thread, the tissue ingrowth member configured for tissue ingrowth; and a locking mechanism positioned on a part of the thread positioned within the hollow sleeve, proximally to the tissue ingrowth member; and pulling the thread proximally, thereby causing tissue associated with the tissue ingrowth member to be lifted towards the entrance point.
  • the pulling is preferably performed following a lag period, which lag period allows tissue ingrowth into the tissue
  • inserting the tissue lagging device comprises penetrating the subject's skin at an entrance point using a tissue piercing element (such as, but not limited to, a trocar attached to the sleeve's distal end), passing the device through the tissue until an exit point in the subject's skin is reached and penetrating the exit point using the tissue piercing element.
  • inserting the tissue lagging device further comprises passing the device through the tissue until a stopper abuts the entrance point, thereby positioning the sleeve within the tissue, between the entrance and exit points.
  • the method further comprises detaching the tissue piercing element from the sleeve, after the penetration of the skin at the exit point.
  • the pulling may be performed using a pulling member (such as, but not limited to, a pulling ring), attached to the thread's proximal end.
  • a pulling member such as, but not limited to, a pulling ring
  • the locking comprises anchoring an anchoring element, positioned on a part of the thread located within the hollow sleeve, proximally to the tissue ingrowth member, to an anchoring site, the anchoring site formed in an inner wall of the sleeve's proximal end.
  • the anchoring element may include one or more unidirectional absorbable cones
  • the anchoring site may include one or more rails configured to secure the one or more cones therein.
  • the method further comprises detaching the stopper and/or the pull member from the sleeve after the locking of the tread within the sleeve.
  • FIG. 1-4 schematically depict a surgical device 150, according to an exemplary embodiment of the current invention, in its various configurations.
  • the number 10 depicts a sharp end of a trocar 20 that allows penetration of a subject's skin at an entrance point (not shown) and provides easy and smooth passage of device 150 through the tissue until penetrating an exit point in the subject's skin (not shown).
  • the number 20 depicts a trocar body being a smooth cone that is hooked to a distal end of a sleeve 70. Once penetrating the skin at the exit point, trocar 20 is preferably detached from sleeve 70.
  • the number 30 depicts a tissue ingrowth member, here a net configured to promote tissue ingrowth into and around tissue ingrowth member 30 for maximal adhesion before pulling and lagging. Tissue ingrowth member 30 is attached/connected to a thread 40.
  • the number 40 depicts an absorbable thread, attached at its distal end to tissue ingrowth member 30.
  • the proximal end of thread 40 may include a locking member, such as the herein depicted unidirectional absorbable cones 50.
  • the number 50 depicts a locking member, here a locking member including absorbable unidirectional cones, configured to engage an absorbable locking site 60.
  • the number 60 depicts a locking site, here a locking site including an absorbable shelf/shelves that allows locking of locking member 50 once they are pulled through the shelf, thereby enabling the lagging of the tissue associated with tissue ingrowth member 30.
  • the number 70 depicts the absorbable hollow sleeve holding therein thread 40 and tissue ingrowth member 30.
  • the number 80 depicts a stopper ring, attached to the proximal end of sleeve 70. Stopper ring 80 is configured to prevent sleeve 70 from moving distally off the entrance point and thus to reinforce/augment the lagging process.
  • the number 90 depicts a proximal part of absorbable thread 30 extending outside the proximal end of sleeve 70.
  • Proximal end 90 includes a pulling ring 100 configured to assist the surgeon in grasping and pulling thread 40.
  • the number 100 depicts the pulling ring that helps to pull the thread and to lock it once the engagement between locking member 50 and locking site 60 is achieved.
  • the number 110 depicts an optional element of absorbable wings/hooks which are positioned on an outer surface of hollow sleeve 70. Wings/hooks 110 are configured to allow solid anchoring of the sleeve's proximal end to soft tissue surrounding it.
  • Device 150 shows an exemplary embodiment of the hereindisclosed absorbable surgical device that aims to achieve a maximal soft tissue pulling effect in a minimally invasive nonsurgical procedure using a unique lagging mechanism. The device may be implanted in a procedure requiring initial pre-procedural marking, and administration of local anesthesia, with or without nerve block.
  • Fig.l depicts device 150 in its initial configuration, at which device 150 is inserted, following the initial preparation and sterilization of a target area.
  • device 150 is attached to a trocar body 20 having a sharp end 10 configured for penetrating a subject's skin (not shown) at an entrance point (not shown) marked thereon.
  • the entrance point is preferably located in an area having relatively solid tissue.
  • Sharp end 10 and trocar body 20 assist in passing device 150 in a distal direction and through the flexible soft tissue to an exit point (not shown) likewise marked on the subject's skin.
  • the exit point is located in the target area, lifting of which is desired.
  • the skin may be penetrated using a separate element, followed by delivery of a device similar to device 150, but devoid of trocar body 20 (embodiment not shown).
  • Fig. 2 depicts device 150 in a second configuration assumed upon reaching an exit point marked on the subject's skin.
  • trocar body 20 is detached from the distal end of sleeve 70, while leaving tissue ingrowth 30 and sleeve 70 completely or partially embedded within the soft tissue.
  • stopper ring 80 is left outside, abutting the entrance point, thus ensuring that sleeve 70 is positioned within the tissue between the entrance and exit points.
  • Proximal end 90 of thread 40 includes pulling ring 100, hanging unrestrained until the pulling act that is carried out after a sufficient ingrowth of tissue into tissue ingrowth member 30 has been achieved.
  • Device 150 is left in place until the tissue ingrowth period around and/or into tissue ingrowth member 30 reaches the optimal reinforcement tissue growth. Once this period ends, ring 100 is pulled and by doing so the movable soft tissue is lifted/lagged distally towards the stable tissue (i.e. towards the entrance point).
  • Fig. 3 shows a third configuration of device 150 in which optionally thread 40 is pulled sufficiently for anchoring member (cones) 50 to engage anchoring site (stopper shelf) 60, thereby locking/immobilizing thread 40 within sleeve 70 and completing the lagging of the soft tissue associated with tissue ingrowth member 30 to the more solid tissue in proximity to the entrance point.
  • Fig. 4 shows a fourth configuration of device 150 in which stopper 80 is detached from sleeve 70 and proximal end 90 of thread 40, including pulling ring 100, is cut off to allow smooth heeling of the entrance point over the proximal section of sleeve 70.
  • absorbable wings 110 attached to the outer surface of sleeve 70, hooks into the surrounding tissue, thereby augmenting the anchoring of sleeve 70 to the solid tissue.
  • the device provides maximal possible adherence between the absorbable device and sagging/wrinkled tissue by facilitating a real and significant lagging between moveable soft tissue and solid soft tissue, and thus provide the best lifting ability of soft tissue.
  • the term "about” refers to a reasonable variation from a stated amount that retains the ability to achieve one or more functional effect to substantially the same extent as the stated amount.
  • the term may also refer herein to a value of plus or minus 10% of the stated value; or plus or minus 5%, or plus or minus 1%, or plus or minus 0.5%, or plus or minus 0.1%, or any percentage in between.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Prostheses (AREA)

Abstract

L'invention concerne un dispositif d'isolation de tissu pour chirurgie plastique, comprenant un manchon creux biocompatible et biorésorbable configuré pour une implantation dans le tissu entre un point d'entrée et un point de sortie dudit tissu ; un fil biocompatible et bioabsorbable ; et un élément de croissance interne de tissu fixé à une extrémité distale du fil, l'élément de croissance interne de tissu étant configuré pour une croissance interne de tissu ; de telle sorte que, lorsque le fil est tiré, le tissu associé à l'élément de croissance interne de tissu est soulevé et/ou décalé vers le tissu solide.
PCT/IL2018/050002 2017-01-03 2018-01-01 Fil chirurgical pour chirurgie plastique WO2018127907A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762441664P 2017-01-03 2017-01-03
US62/441,664 2017-01-03

Publications (1)

Publication Number Publication Date
WO2018127907A1 true WO2018127907A1 (fr) 2018-07-12

Family

ID=62790927

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2018/050002 WO2018127907A1 (fr) 2017-01-03 2018-01-01 Fil chirurgical pour chirurgie plastique

Country Status (1)

Country Link
WO (1) WO2018127907A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004410A1 (en) * 2004-05-14 2006-01-05 Nobis Rudolph H Suture locking and cutting devices and methods
EP2774579A1 (fr) * 2011-10-31 2014-09-10 Jong Woo Kim Greffon pour rhytidectomie tissulaire
US20150005815A1 (en) * 2009-11-24 2015-01-01 Covidien Lp Wound plugs

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004410A1 (en) * 2004-05-14 2006-01-05 Nobis Rudolph H Suture locking and cutting devices and methods
US20150005815A1 (en) * 2009-11-24 2015-01-01 Covidien Lp Wound plugs
EP2774579A1 (fr) * 2011-10-31 2014-09-10 Jong Woo Kim Greffon pour rhytidectomie tissulaire

Similar Documents

Publication Publication Date Title
CN102056552B (zh) 具有双向保持器或单向保持器的自保持缝合线
CN112618107B (zh) 用于心脏瓣膜修复的医学植入物及方法
KR100885341B1 (ko) 원거리 부착 조직 고정 장치 및 방법
JP4748813B2 (ja) 吸収性固定具および適用装置
JP5518737B2 (ja) 熱接触媒介リテーナを備えた留置縫合糸
US9707069B2 (en) Suture mesh and method of use
US20100331612A1 (en) Minimally invasive tissue support system and method with a superior tissue support and an inferior anchor
US9700298B2 (en) Tissue repair suture plates and methods of use
EP3305247A2 (fr) Procédé et moyen pour attacher des sutures d'ancrage sur des implants en treillis
RU2708217C2 (ru) Шовный материал для фиксации мягких тканей
WO2012116319A9 (fr) Maille de suture et son procédé d'utilisation
JP2016517766A (ja) 美容増進のためのシステム
EP3651671B1 (fr) Système d'ancrage à double fonction
US11547397B2 (en) Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
JP6189337B2 (ja) 植え込み可能本体用薬物溶出挿入部材
WO2018127907A1 (fr) Fil chirurgical pour chirurgie plastique
US20230233200A1 (en) Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
WO2016025019A1 (fr) Dispositif de fixation tissulaire dans une aiguille

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18735865

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18735865

Country of ref document: EP

Kind code of ref document: A1